When an oncologist learns one patient’s story, everything shifts, including his approach to consultations. Medscape Medical News Source link : https://www.medscape.com/viewarticle/doctor-helps-woman-stop-blaming-herself-and-accept-treatment-2026a1000i20?src=rss Author : Publish date : 2026-05-30 20:22:00 Copyright for...

TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech...

Patients in full remission from endometrial cancer who underwent fertility-preserving treatment before cancer treatment had less IVF success than matched controls.The question remains as to what exactly drives this difference...

I have spent 20 years working in out-of-network healthcare reimbursement. After reading the New York Times article "A $440,000 Breast Reduction? How Doctors Cash In on a Health Care Law,"...

CHICAGO -- Combining two targeted therapies with standard-of-care chemotherapy extended progression-free survival (PFS) in patients with newly diagnosed B-cell lymphomas, according to data from the frontMIND trial. In the phase...

President Donald Trump on Friday gave his endorsement to a January study by HHS that calls for cutting the number of vaccines recommended for every American child. An executive order...

Editor's Note: This story includes discussion of suicide. If you or someone you know needs help, the national suicide and crisis lifeline in the U.S. is available by calling or...

The largest randomized trial of its kind to date found noninferior survival and better arm morbidity among patients with breast cancer who did not undergo completion axillary lymph node dissection....

Tafasitamab and lenalidomide are likely to be approved with R-CHOP for frontline DLBCL, but with bispecific antibodies on the horizon, the role of the combination is uncertain. Medscape Medical News...

The GammaTile may improve outcomes over standard stereotactic RT after resection of large brain metastases, but a striking overall survival benefit in a phase 3 trial raises questions. Medscape Medical...

CHICAGO -- Radioactive tiles implanted immediately after the surgical resection of a newly diagnosed brain metastasis improved local control over standard stereotactic radiotherapy (SRT) given weeks later, findings of a...

CHICAGO -- Adding a multicancer early detection (MCED) blood test to standard of care did not reduce the number of cancers detected at stage III or IV across a dozen...

CHICAGO -- Skipping axillary lymph node dissection (ALND) for selected patients with locally advanced breast cancer did not adversely affect survival, findings from a randomized trial showed. Patients who omitted...

A father mysteriously slips through time in Joseph Eckert’s The TravelerMikhail Rudenko / Alamy Writing this as the UK swelters under an unprecedented May heatwave, perhaps it’s small wonder that...

A new DNA test could help screen whether patients require the treatment or not, according to a new international trial. Source link : https://www.bbc.com/news/articles/c2325j0xk1vo?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-05-30...

In a memo released by the White House on Friday, Capt Sean Barbabella said Trump, who turns 80 next month, has "strong cardiac, pulmonary, neurological and overall physical function" and...

Share on PinterestSome people are more prone to mosquito bites than others, and scientists may have figured out why. Jaromir/Getty ImagesResearchers have identified several reasons why mosquitoes are more attracted...

Cutting photons is infinitely weirdMuhammad Fawaid/Alamy In Greek mythology, cutting one head off the Hydra of Lerna simply resulted in two more heads growing to replace it – and it...

The plans are part of a government bill to modernise the NHS in England, which is currently going through parliament. Source link : https://www.bbc.com/news/articles/cn8pn2jplg9o?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-05-30...

CHICAGO -- An oral targeted drug reduced the risk of disease progression or death by 35% compared with chemotherapy when given as first-line treatment for non-small cell lung cancer (NSCLC)...